Pathogenic mechanisms of influenza A(H1N1)pdm09 infection elucidated on gene expression profiling

The pathogenic mechanisms underlying influenza A(H1N1)pdm09‐associated central nervous system (CNS) manifestations and pneumonia remain unclear. This study examined A(H1N1)pdm09 host responses using gene expression profiles of patients’ peripheral blood.

[1]  Jianguo Wu,et al.  High-throughput screen of protein expression levels induced by cyclooxygenase-2 during influenza a virus infection. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[2]  K. Shirabe,et al.  Serum and cerebrospinal fluid cytokine profile of patients with 2009 pandemic H1N1 influenza virus-associated encephalopathy. , 2011, Cytokine.

[3]  M. Imai,et al.  Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza , 2011, Microbiology and immunology.

[4]  R. P. Arya,et al.  Role of Host Immune Response and Viral Load in the Differential Outcome of Pandemic H1N1 (2009) Influenza Virus Infection in Indian Patients , 2010, PloS one.

[5]  Y. Kashiwagi,et al.  Cytokine and chemokine response in children with the 2009 pandemic influenza A (H1N1) virus infection , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[6]  M. Pinon,et al.  Clinical features of hospitalised children with 2009 H1N1 influenza virus infection , 2010, European Journal of Pediatrics.

[7]  D. Hui,et al.  Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. , 2010, The New England journal of medicine.

[8]  P. Kochanek,et al.  Neurological sequelae of 2009 influenza A (H1N1) in children: A case series observed during a pandemic* , 2010, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[9]  N. Halasa Update on the 2009 pandemic influenza A H1N1 in children , 2010, Current opinion in pediatrics.

[10]  S. O'Riordan,et al.  Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza , 2010, Canadian Medical Association Journal.

[11]  J. Rello,et al.  Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza , 2009, Critical care.

[12]  Gavin J. D. Smith,et al.  Molecular Detection of a Novel Human Influenza (H1N1) of Pandemic Potential by Conventional and Real-Time Quantitative RT-PCR Assays , 2009, Clinical chemistry.

[13]  Y. Guan,et al.  Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. , 2008, The Journal of infectious diseases.

[14]  M. Mizuguchi,et al.  Acute encephalopathy associated with influenza and other viral infections , 2007, Acta neurologica Scandinavica. Supplementum.

[15]  R. Keren,et al.  Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors. , 2007, The Journal of pediatrics.

[16]  H. Kurahashi,et al.  Analysis of gene-expression profiles by oligonucleotide microarray in children with influenza. , 2006, The Journal of general virology.

[17]  Martin F. Bachmann,et al.  Interleukin-1 Is Responsible for Acute Lung Immunopathology but Increases Survival of Respiratory Influenza Virus Infection , 2005, Journal of Virology.

[18]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[19]  E. Peles,et al.  Caspr3 and Caspr4, Two Novel Members of the Caspr Family Are Expressed in the Nervous System and Interact with PDZ Domains , 2002, Molecular and Cellular Neuroscience.

[20]  P. Calder,et al.  Fatty acids and lymphocyte functions , 2002, British Journal of Nutrition.

[21]  A. Lechtermann,et al.  Exercise affects the gene expression profiles of human white blood cells. , 2007, Journal of applied physiology.